Isolation and Characterization of an Abnormal High Density Lipoprotein in Tangier Disease
Open Access
- 1 July 1977
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 60 (1), 242-252
- https://doi.org/10.1172/jci108761
Abstract
The nature of the high density lipoproteins has been investigated in five patients homozygous for Tangier disease (familial high density lipoprotein deficiency). It has been established that Tangier high density lipoproteins, as isolated by ultracentrifugation, are morphologically heterogenous and contain several proteins (Apo B, albumin, and Apo A-II). An abnormal lipoprotein has been isolated from the d = 1.063-1.21 g/ml ultracentrifugal fraction by agarose-column chromatography which contains apoprotein A-II as the sole protein constituent. In negative-stain electron microscopy, these lipoproteins appeared as spherical particles 55-75 Å in diameter. By a variety of criteria (immunochemical, polyacrylamide electrophoresis, amino acid composition, and fluorescence measurements), apoprotein A-I the major apoprotein of normal high density lipoproteins and the C apoproteins were absent from this lipoprotein. As demonstrated by 125I very low density lipoprotein incubation experiments with Tangier plasma, C apoproteins did not associate with lipoproteins of d = 1.063-1.21 g/ml. Tangier apoprotein A-II, isolated to homogeneity by delipidation of the apoprotein A-II-containing lipoprotein or Sephadex G-200 guanidine-HCl chromatography of the d = 1.063-1.21 g/ml fraction, was indistinguishable from control apoprotein A-II with respect to amino acid composition and migration of tryptic peptides in urea-polyacrylamide electrophoresis. The ability of Tangier apoprotein A-II to bind phospholipid was demonstrated by in vitro reconstitution experiments and morphological and chemical analysis of lipid-protein complexes. It is concluded that normal high density lipoproteins, as defined by polypeptide composition and morphological appearance, are absent from Tangier plasma and that as a consequence, the impairment of C apoprotein metabolism contributes to the hypertriglyceridemia and fasting chylomicronemia observed in these patients.This publication has 43 references indexed in Scilit:
- The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins.Journal of Clinical Investigation, 1977
- An abnormal high density lipoprotein in cholestatic plasma isolated by zonal ultracentrifugationFEBS Letters, 1975
- On the polypeptide composition of an abnormal high density lipoprotein (LP‐E) occurring in LCAT‐deficient plasmaFEBS Letters, 1974
- Identification of the lipid-binding cyanogen bromide fragment from the cystine-containing high density apolipoprotein, ApoLP-Gln-IIBiochemical and Biophysical Research Communications, 1972
- The metabolism of very low density lipoprotein proteins I. Preliminary in vitro and in vivo observationsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1972
- A protein cofactor of lecithin:Cholesterol acyltransferaseBiochemical and Biophysical Research Communications, 1972
- A Simple Chemical Method for Labelling Phosphatidylcholine and Sphingomyelin in the Choline MoietyHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1971
- Computed circular dichroism spectra for the evaluation of protein conformationBiochemistry, 1969
- Tangier disease (familial high density lipoprotein deficiency)American Journal Of Medicine, 1965
- Studies in accelerated amino acid analysisBiochemical and Biophysical Research Communications, 1965